- Soluble Suppression of Tumorigenicity 2 and Echocardiography in Sepsis
-
Yang HS, Hur M, Kim H, Magrini L, Marino R, Di Somma S, GREAT Network
- KMID: 2373598
- Ann Lab Med.
- 2016 Nov;36(6):590-594.
- doi: 10.3343/alm.2016.36.6.590
Soluble suppression of tumorigenicity 2 (sST2) has emerged as a biomarker of cardiac stretch or remodeling, and has demonstrated a role in acutely decompensated heart failure. However, its role in... -
- CITED
-
- Close
- SHARE
-
- Close
- Lack of Superiority for Soluble ST2 over High Sensitive C-Reactive Protein in Predicting High Risk Coronary Artery Calcium Score in a Community Cohort
-
Oh J, Park S, Yu HT, Chang HJ, Lee SH, Kang SM, Choi D
- KMID: 2427151
- Yonsei Med J.
- 2016 Nov;57(6):1347-1353.
- doi: 10.3349/ymj.2016.57.6.1347
PURPOSE: Soluble ST2 (sST2) is an emerging prognostic biomarker in patients with cardiovascular disease (CVD). A recent study showed that sST2 predicted incident hypertension. High sensitive C-reactive protein (hsCRP) has... -
- CITED
-
- Close
- SHARE
-
- Close
- Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis
-
Hur M, Kim H, Kim HJ, Yang HS, Magrini L, Marino R, Cardelli P, Di Somma S, GREAT Network
- KMID: 2363259
- Ann Lab Med.
- 2015 Nov;35(6):570-577.
- doi: 10.3343/alm.2015.35.6.570
BACKGROUND: Soluble suppression of tumorigenicity 2 (sST2) has emerged as a novel biomarker for heart failure, and serum sST2 concentrations could be increased in inflammatory diseases. We explored whether sST2... -
- CITED
-
- Close
- SHARE
-
- Close
- Soluble ST2 Levels and Left Ventricular Structure and Function in Patients With Metabolic Syndrome
-
Celic V, Majstorovic A, Pencic-Popovic B, Sljivic A, Lopez-Andres N, Roy I, Escribano , Beunza M, Melero A, Floridi F, Magrini L, Marino R, Salerno G, Cardelli P, Di Somma S
- KMID: 2373592
- Ann Lab Med.
- 2016 Nov;36(6):542-549.
- doi: 10.3343/alm.2016.36.6.542
BACKGROUND: A biomarker that is of great interest in relation to adverse cardiovascular events is soluble ST2 (sST2), a member of the interleukin family. Considering that metabolic syndrome (MetS) is... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain
-
Marino R, Magrini L, Orsini F, Russo V, Cardelli P, Salerno G, Hur M, Di Somma S, GREAT NETWORK
- KMID: 2373631
- Ann Lab Med.
- 2017 Mar;37(2):137-146.
- doi: 10.3343/alm.2017.37.2.137
BACKGROUND: High-sensitivity cardiac troponin I (hs-cTnI) and the soluble isoform of suppression of tumorigenicity 2 (sST2) are useful prognostic biomarkers in acute coronary syndrome (ACS). The aim of this study... -
- CITED
-
- Close
- SHARE
-
- Close
